Canada Molecular Diagnostics Market Size & Outlook

The molecular diagnostics market in Canada is expected to reach a projected revenue of US$ 1,189.2 million by 2030. A compound annual growth rate of 3.1% is expected of Canada molecular diagnostics market from 2025 to 2030.
Revenue, 2024 (US$M)
$966.6
Forecast, 2030 (US$M)
$1,189.2
CAGR, 2025 - 2030
3.1%
Report Coverage
Canada

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Canada molecular diagnostics market, 2018-2030 (US$M)

Canada molecular diagnostics market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Related Markets

Canada molecular diagnostics market highlights

  • The Canada molecular diagnostics market generated a revenue of USD 966.6 million in 2024 and is expected to reach USD 1,189.2 million by 2030.
  • The Canada market is expected to grow at a CAGR of 3.1% from 2025 to 2030.
  • In terms of segment, reagents was the largest revenue generating product in 2024.
  • Reagents is the most lucrative product segment registering the fastest growth during the forecast period.


Molecular diagnostics market data book summary

Market revenue in 2024USD 966.6 million
Market revenue in 2030USD 1,189.2 million
Growth rate3.1% (CAGR from 2025 to 2030)
Largest segmentReagents
Fastest growing segmentReagents
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationInstruments, Reagents


Other key industry trends

  • In terms of revenue, Canada accounted for 3.8% of the global molecular diagnostics market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In North America, U.S. molecular diagnostics market is projected to lead the regional market in terms of revenue in 2030.
  • U.S. is the fastest growing regional market in North America and is projected to reach USD 11,932.0 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Molecular Diagnostics Market Scope

Molecular diagnostics market segmentation & scope

Molecular Diagnostics Market Companies

Name Profile # Employees HQ Website
F. Hoffmann-La Roche Ltd. View profile - - -
Sysmex Corp View profile 10448 1-5-1 Wakinohara-Kaigandori, Chuo-ku, Hyogo Prefecture, Kobe, Japan, 6510073 http://www.sysmex.co.jp
Hologic Inc View profile 6990 250 Campus Drive, Marlborough, MA, United States, 01752 http://www.hologic.com
Qiagen NV View profile 5900 Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL https://www.qiagen.com
Bio-Rad Laboratories Inc View profile 8030 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 https://www.bio-rad.com
Agilent Technologies Inc View profile 17700 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 https://www.agilent.com
Illumina Inc View profile 9300 5200 Illumina Way, San Diego, CA, United States, 92122 https://www.illumina.com
Danaher Corp View profile 63000 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 https://www.danaher.com
Siemens Healthineers AG ADR View profile 71400 Siemensstr. 3, Forchheim, BY, Germany, 91301 https://www.siemens-healthineers.com
BioMerieux SA View profile 13982 Marcy l’Etoile, Lyon, France, 69280 http://www.biomerieux.com
Becton Dickinson & Co View profile 73000 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 https://www.bd.com
Abbott Laboratories View profile 114000 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 https://www.abbottinvestor.com

Canada molecular diagnostics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to molecular diagnostics market will help companies and investors design strategic landscapes.


Reagents was the largest segment with a revenue share of 68.14% in 2024. Horizon Databook has segmented the Canada molecular diagnostics market based on instruments, reagents covering the revenue growth of each sub-segment from 2018 to 2030.


The rising number of cancer cases highlights an increasing need for advanced molecular diagnostics to enable early detection and personalized treatment, driving market growth. According to the Canadian Cancer Society, an estimated 247,100 Canadians will be diagnosed with cancer in 2024, up from 239,100 new cases in 2023.

This increase is largely attributed to Canada's growing and aging population. Additionally, cancer-related deaths are projected to rise from 86,700 in 2023 to 88,100 in 2024. The Colorectal Cancer Association of Canada and the Canadian Cancer Society provide dedicated services to improve quality of life and deliver sophisticated medical care to patients to reduce the prevalence of colorectal cancer.

Reasons to subscribe to Canada molecular diagnostics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Canada molecular diagnostics market databook

  • Our clientele includes a mix of molecular diagnostics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Canada molecular diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Canada molecular diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Canada Product - Molecular Diagnostics Market size, 2024 - 2030 (US$M)

Canada Molecular Diagnostics Market Outlook Share, 2024 & 2030 (US$M)

Canada Product - Molecular Diagnostics Market size, 2024 - 2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online